Senior insider sale
Chief Financial Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$10.37M
104.93K shares
SONI MANMEET SINGH plans to sell 104.93K shares of REATA PHARMACEUTICALS INC valued at approximately $10.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Broker assisted cashless exercise
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Open market purchase
Cash
Open market purchase
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/13/2023 | Exercise of employee stock options Broker assisted cashless exercise | 25K | — |
5/15/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 845.00 | — |
5/12/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 31.62K | — |
3/6/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.47K | — |
3/2/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 8.29K | — |
1/3/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 3.13K | — |
10/25/2022 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.54K | — |
12/31/2021 | Open market purchase Cash | 3.20K | — |
8/14/2020 | Open market purchase Cash | 3K | — |
| Total | 78.08K | ||
Completed
Units to sell
4.71K
Market value
$469.3K
Units to sell
625.00
Market value
$50.6K
Units to sell
21.51K
Market value
$1.82M
Planned — Approximate Date
Units to sell
78.08K
Market value
$8.03M
Units
104.93K
Value
$10.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/12/2023 | 4.71K | $469.3K | — | Completed |
5/16/2023 | 625.00 | $50.6K | — | Completed |
5/15/2023 | 21.51K | $1.82M | — | Completed |
| Planned — Approximate Date | ||||
6/13/2023 | 78.08K | $8.03M | NASDAQ | Planned |
| Total | 104.93K | $10.37M | ||